Second neoplasm in patients with head and neck cancer
- PMID: 10208662
- DOI: 10.1002/(sici)1097-0347(199905)21:3<204::aid-hed4>3.0.co;2-7
Second neoplasm in patients with head and neck cancer
Abstract
Background: The improvement in locoregional control of head and neck carcinomas over the last decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms. We ran a study to evaluate the incidence of second neoplasms and their characteristics in patients with head and neck carcinoma treated in our hospital.
Methods: A retrospective study was undertaken to analyze the appearance of second neoplasm, its characteristics, and repercussion on the survival in 1845 patients with carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx diagnosed and treated in our department between 1984 and 1995.
Results: A group of 302 patients (16%) developed a second neoplasm. The incidence of second neoplasms was 4% per year and was constant during the follow-up period. Second neoplasms were mainly carcinomas located in head and neck (40%), lungs (31%), or esophagus (9%). Twenty percent of second neoplasms were tumors located outside the aerodigestive tract. The appearance of a second neoplasm significantly worsened the survival.
Conclusions: Four percent per year of patients with carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx develop a second neoplasm, most frequently a carcinoma of the aerodigestive tract. This leads to a significant worsening of survival.
Similar articles
-
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028. Laryngoscope. 2001. PMID: 11404625
-
Second, third, and fourth head and neck tumors. A progressive decrease in survival.Head Neck. 2012 Dec;34(12):1716-9. doi: 10.1002/hed.21977. Epub 2012 Feb 6. Head Neck. 2012. PMID: 22307753
-
Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis.Acta Otorrinolaringol Esp (Engl Ed). 2023 Nov-Dec;74(6):339-345. doi: 10.1016/j.otoeng.2022.10.009. Epub 2023 May 5. Acta Otorrinolaringol Esp (Engl Ed). 2023. PMID: 37149128
-
Synchronous and metachronous head and neck carcinomas.Cancer. 1994 Oct 1;74(7):1933-8. doi: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. Cancer. 1994. PMID: 8082099 Review.
-
Incidence and sites of distant metastases from head and neck cancer.ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):202-7. doi: 10.1159/000055740. ORL J Otorhinolaryngol Relat Spec. 2001. PMID: 11408812 Review.
Cited by
-
Causes of death after laryngeal cancer diagnosis: A US population-based study.Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1855-1864. doi: 10.1007/s00405-022-07730-y. Epub 2022 Nov 10. Eur Arch Otorhinolaryngol. 2023. PMID: 36357608 Free PMC article.
-
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy.NPJ Precis Oncol. 2019 Sep 27;3:22. doi: 10.1038/s41698-019-0097-y. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31583278 Free PMC article.
-
p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients.Eur Arch Otorhinolaryngol. 2009 Apr;266(4):547-51. doi: 10.1007/s00405-008-0780-z. Epub 2008 Aug 8. Eur Arch Otorhinolaryngol. 2009. PMID: 18688630
-
Clinical significance of early detection of esophageal cancer in patients with head and neck cancer.Gut Liver. 2015 Mar;9(2):159-65. doi: 10.5009/gnl13401. Gut Liver. 2015. PMID: 25167869 Free PMC article.
-
Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.Oncotarget. 2017 Feb 7;8(6):10255-10263. doi: 10.18632/oncotarget.14381. Oncotarget. 2017. PMID: 28052013 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous